相关实验视频
Updated: Jun 14, 2026

08:32
Extraction of Tissue Antigens for Functional Assays
Published on: September 10, 2012
10.9K
对病态IAPP聚合物的人类抗体保护2型糖尿病模型中的β细胞
Fabian Wirth1, Fabrice D Heitz1, Christine Seeger1
1Neurimmune AG, Wagistrasse 18, 8952, Schlieren, Switzerland.
Nature communications
|October 9, 2023
概括
一种新的抗体向有毒的小岛氨基多 (IAPP) 寡合体,保护胰腺β细胞. 这种方法清除了IAPP聚合物,改善了2型糖尿病模型中的葡萄糖控制.
科学领域:
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 2型糖尿病涉及逐渐的胰腺β细胞损失和功能障碍.
- 岛屿粉样聚 (IAPP) 聚合成寡合体和纤维素有助于β细胞衰竭.
- IAPP聚合物破坏细胞膜并诱导细胞亡,损害胰岛素的产生.
研究的目的:
- 开发和评估一种向有毒IAPP寡合体的人类单克隆抗体.
- 在2型糖尿病模型中研究抗体介导的IAPP寡合体清除的治疗潜力.
主要方法:
- 开发一种特定于IAPP寡合体的人类单克隆抗体.
- 在体外测试以评估IAPP总体毒性的抗体中和.
- 在体内研究使用转基因大鼠/小鼠和人类小岛植入的小鼠患有2型糖尿病.
主要成果:
- 该抗体选择性地向IAPP寡合体,并防止细胞膜破坏和细胞亡在体外.
- 在体内进行抗体治疗导致IAPP寡合体的清除.
- 在动物模型中,治疗导致显著的β细胞保护和改善葡萄糖调节.
结论:
- IAPP的寡合体在2型糖尿病中起着关键的病理作用.
- 抗体介导的IAPP寡合体清除代表了一种有前途的治疗策略,用于维护β细胞功能和管理2型糖尿病.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

